Unknown

Dataset Information

Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors.


ABSTRACT:

Background

The clinical success of immune checkpoint inhibitors demonstrates that reactivation of the human immune system delivers durable responses for some patients and represents an exciting approach for cancer treatment. An important class of preclinical in vivo models for immuno-oncology is immunocompetent mice bearing mouse syngeneic tumors. To facilitate translation of preclinical studies into human, we characterized the genomic, transcriptomic, and protein expression of a panel of ten commonly used mouse tumor cell lines grown in vitro culture as well as in vivo tumors.

Results

Our studies identified a number of genetic and cellular phenotypic differences that distinguish commonly used mouse syngeneic models in our study from human cancers. Only a fraction of the som

SUBMITTER: Zhong W 

PROVIDER: S-EPMC6941261 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature